- Home
- RAPT vs TNYA Comparison
RAPT vs TNYA Comparison
Compare RAPT & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- TNYA
- Stock Information
- Founded
- RAPT 2015
- TNYA 2016
- Country
- RAPT United States
- TNYA United States
- Employees
- RAPT N/A
- TNYA N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- RAPT Health Care
- TNYA Health Care
- Exchange
- RAPT Nasdaq
- TNYA Nasdaq
- Market Cap
- RAPT 194.2M
- TNYA 189.1M
- IPO Year
- RAPT 2019
- TNYA 2021
- Fundamental
- Price
- RAPT $13.18
- TNYA $1.31
- Analyst Decision
- RAPT Buy
- TNYA Strong Buy
- Analyst Count
- RAPT 5
- TNYA 5
- Target Price
- RAPT $33.60
- TNYA $8.60
- AVG Volume (30 Days)
- RAPT 117.5K
- TNYA 4.7M
- Earning Date
- RAPT 08-07-2025
- TNYA 11-05-2025
- Dividend Yield
- RAPT N/A
- TNYA N/A
- EPS Growth
- RAPT N/A
- TNYA N/A
- EPS
- RAPT N/A
- TNYA N/A
- Revenue
- RAPT N/A
- TNYA N/A
- Revenue This Year
- RAPT N/A
- TNYA N/A
- Revenue Next Year
- RAPT N/A
- TNYA N/A
- P/E Ratio
- RAPT N/A
- TNYA N/A
- Revenue Growth
- RAPT N/A
- TNYA N/A
- 52 Week Low
- RAPT $5.67
- TNYA $0.36
- 52 Week High
- RAPT $26.56
- TNYA $4.01
- Technical
- Relative Strength Index (RSI)
- RAPT 63.64
- TNYA 66.07
- Support Level
- RAPT $11.19
- TNYA $1.05
- Resistance Level
- RAPT $13.66
- TNYA $1.43
- Average True Range (ATR)
- RAPT 0.75
- TNYA 0.10
- MACD
- RAPT 0.19
- TNYA 0.01
- Stochastic Oscillator
- RAPT 86.53
- TNYA 68.42
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.